Your browser doesn't support javascript.
loading
Reply to B.L. King-Kallimanis et al.
Friedman, Daphne R; Halwani, Ahmad S; Kelley, Michael J.
Afiliación
  • Friedman DR; Daphne R. Friedman, MD, Division of Medical Oncology, Duke University School of Medicine, Durham, NC, Durham Veterans Administration Health Care System, Durham, NC; Ahmad S. Halwani, MD, George E. Wahlen Veterans Health Administration, Salt Lake City, UT, Division of Epidemiology, VERITAS, University of Utah, Salt Lake City, UT, Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, Salt Lake City, UT; and Michael J. Kelley, MD, Division of Medical Oncology, Duke Univers
  • Halwani AS; Daphne R. Friedman, MD, Division of Medical Oncology, Duke University School of Medicine, Durham, NC, Durham Veterans Administration Health Care System, Durham, NC; Ahmad S. Halwani, MD, George E. Wahlen Veterans Health Administration, Salt Lake City, UT, Division of Epidemiology, VERITAS, University of Utah, Salt Lake City, UT, Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, Salt Lake City, UT; and Michael J. Kelley, MD, Division of Medical Oncology, Duke Univers
  • Kelley MJ; Daphne R. Friedman, MD, Division of Medical Oncology, Duke University School of Medicine, Durham, NC, Durham Veterans Administration Health Care System, Durham, NC; Ahmad S. Halwani, MD, George E. Wahlen Veterans Health Administration, Salt Lake City, UT, Division of Epidemiology, VERITAS, University of Utah, Salt Lake City, UT, Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, Salt Lake City, UT; and Michael J. Kelley, MD, Division of Medical Oncology, Duke Univers
JCO Clin Cancer Inform ; 6: e2200075, 2022 07.
Article en En | MEDLINE | ID: mdl-35878070

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: JCO Clin Cancer Inform Año: 2022 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: JCO Clin Cancer Inform Año: 2022 Tipo del documento: Article